Back to: HealthBeat
June 04, 2014 02:15 PM

SD, 44 States Settle With GlaxoSmithKline

Pierre, SD

A multinational drugmaker is paying 45 states including South Dakota $105 million to settle complaints that the company unlawfully marketed three drugs.

South Dakota Attorney General Marty Jackley says South Dakota's share of the settlement is nearly $1.2 million.

The settlement resolves allegations that London-based Glaxo illegally marketed Advair, Paxil and Wellbutrin for purposes that had not been approved by the Food and Drug Administration. Once the FDA approves a drug as safe and effective, a manufacturer cannot market or promote that drug for an unapproved use, a practice called off-label marketing.

The asthma treatment Advair is Glaxo's best-selling product. Paxil and Wellbutrin are antidepressant drugs.

  • News
  • Courts
  • HealthBeat
  • Health Beat
2039 Views
Sponsored